References
- Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329 (18): 1328.
- Moro ML, Stazi MA, Marasca G, et al. National preva-lence of hospital-acquired infections in Italy. J Hosp Infect 1983; 8: 72–85.
- de LaIla F, Eandi M. Indagine sull'uso di antibiotici nel trattamento delle basse vie respiratorie negli ospedali italiani: considerazioni farmacoeconomiche. Giorn Ital Chemioter 1998; 45: 55–83.
- Hootom TM, Stamm WE. Management of acute uncom-plicated urinary tract infections. Med Clin N Am 1991; 11: 551–581.
- Cairns J, Shackley P. The dog in the manger. Lancet 1995; 346: 10.
- Drummond MF, Stoddard GL, Torrance GW. Methods for the evaluation of Health Programmes. Oxford University Press, 1997.
- Karlsson G, Johannesson D. The decision rules of cost-effectiveness analysis. PharmacoEconomics 1996; 2: 113–120.
- The Medical Letter on Drugs and Therapeutics Handbook of antimicrobial therapy. New Rochelle, New York, 1998 Edition.
- Bondonio PV, Eandi M. Tempi e costi di lavoro asso-ciati al trattamento farmacologico: analisi di alcune opportu-nita di risparmio. Farmacoeconomia 1995; 2: 36–45.
- Werthmeier Al. The defined daily dose system (DDD) for drug utilisation review. Hosp Pharm 1986; 21: 233–258.
- Javier E. Optimal use of antibiotics. In: Wenzel RP eds. Prevention and control of nosocomial infections, Baltimore: Williams & Wilkins, 1997: 323 —338.
- Thomas JK, Forrest A, Bhavnani SM, et al. Pharmacodynamic evaluation of factors associated with devel-opment of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998; 42: 521–527.
- Lipsy RJ. Institutional Formularies. The relevance of pharmacoeconomic analysis to formulary decisions. PharmacoEconomics 1992; 1: 265–281.
- Cano SB, Fujita NK. Formulary evaluation of third-gen-eration cephalosporins using decision analysis. Am J Hosp Pharm 1988; 45: 566–569.
- Janknegt R, Stobberingh E. The system of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion. Drugs 1997; 53: 550–562.
- Destky AS. Using cost-effectiveness analysis for formu-lary decision making (from theory into practice). PharmacoEconomics 1994; 6: 281–284.
- Sanchez LA. Pharmacoeconomics and formulary deci-sion making. PharmacoEconomics1996; 9 (Suppl. 1): 16-25.
- Sloan FA, Whetten-Goldstein K, Wilson A. Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis. Soc Sci Med 1997; 45: 523–33.
- Bakst A. Pharmacoeconomics and the formulary deci-sion making process. Hosp Formulary 1995; 30: 42–50.